Literature DB >> 21993687

A A386G biallelic GPIbα gene mutation with anomalous behavior: a new mechanism suggested for Bernard-Soulier syndrome pathogenesis.

Silvia Vettore1, Fabiana Tezza, Alessandro Malara, Fabrizio Vianello, Alessandro Pecci, Raffaella Scandellari, Matteo Floris, Alessandra Balduini, Fabrizio Fabris.   

Abstract

Platelet glycoprotein GPIbα mutations are the basic defect behind Bernard-Soulier syndrome, a rare inherited macrothrombocytopenia characterized by anomalies of the GPIbα, GPIbβ and GPIX subunits of von Willebrand factor receptor. A 32-year old man was investigated for suspected Bernard-Soulier syndrome. Ristocetin induced agglutination was absent. Flow cytometry and Western blot analysis showed a severe reduction in GPIbα, but sequencing revealed only a biallelic c.386A>G substitution, theoretically leading to a p.Asn110Glu variation. To further clarify the data, megakaryocyte cultures were set. Though the maturation of megakaryocytes was normal, proplatelet formation was defective and GPIbα mRNA was not detectable. GPIX protein was slightly reduced and GPIbβ polypeptide almost absent. Computational analysis showed that the c.386A>G mutation disrupted an exon splicing enhancer motif involved in the proper maturation of the GPIbα transcript. The c.386A>G mutation suggests a unique mutational mechanism causing the virtual absence of GPIbα without creating a stop codon.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21993687      PMCID: PMC3232274          DOI: 10.3324/haematol.2010.039008

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  24 in total

1.  A dinucleotide deletion results in defective membrane anchoring and circulating soluble glycoprotein Ib alpha in a novel form of Bernard-Soulier syndrome.

Authors:  D Kenny; P J Newman; P A Morateck; R R Montgomery
Journal:  Blood       Date:  1997-10-01       Impact factor: 22.113

2.  The glycoprotein Ib-IX complex-specific monoclonal antibody SZ1 binds to a conformation-sensitive epitope on glycoprotein IX: implications for the target antigen of quinine/quinidine-dependent autoantibodies.

Authors:  J A López; C Q Li; S Weisman; M Chambers
Journal:  Blood       Date:  1995-03-01       Impact factor: 22.113

3.  Type I collagen CNBr peptides: species and behavior in solution.

Authors:  A Rossi; L V Zuccarello; G Zanaboni; E Monzani; K M Dyne; G Cetta; R Tenni
Journal:  Biochemistry       Date:  1996-05-14       Impact factor: 3.162

4.  The origin, development and regulation of megakaryocytes.

Authors:  N Williams; R F Levine
Journal:  Br J Haematol       Date:  1982-10       Impact factor: 6.998

5.  Clinical and genetic aspects of Bernard-Soulier syndrome: searching for genotype/phenotype correlations.

Authors:  Anna Savoia; Annalisa Pastore; Daniela De Rocco; Elisa Civaschi; Mariateresa Di Stazio; Roberta Bottega; Federica Melazzini; Valeria Bozzi; Alessandro Pecci; Silvana Magrin; Carlo L Balduini; Patrizia Noris
Journal:  Haematologica       Date:  2010-12-20       Impact factor: 9.941

6.  Autosomal dominant macrothrombocytopenia in Italy is most frequently a type of heterozygous Bernard-Soulier syndrome.

Authors:  A Savoia; C L Balduini; M Savino; P Noris; M Del Vecchio; S Perrotta; S Belletti; A Iolascon
Journal:  Blood       Date:  2001-03-01       Impact factor: 22.113

7.  Variant Bernard-Soulier syndrome type bolzano. A congenital bleeding disorder due to a structural and functional abnormality of the platelet glycoprotein Ib-IX complex.

Authors:  L De Marco; M Mazzucato; F Fabris; D De Roia; P Coser; A Girolami; V Vicente; Z M Ruggeri
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

8.  Bernard-Soulier syndrome Kagoshima: Ser 444-->stop mutation of glycoprotein (GP) Ib alpha resulting in circulating truncated GPIb alpha and surface expression of GPIb beta and GPIX.

Authors:  S Kunishima; H Miura; H Fukutani; H Yoshida; K Osumi; S Kobayashi; R Ohno; T Naoe
Journal:  Blood       Date:  1994-11-15       Impact factor: 22.113

9.  ESEfinder: A web resource to identify exonic splicing enhancers.

Authors:  Luca Cartegni; Jinhua Wang; Zhengwei Zhu; Michael Q Zhang; Adrian R Krainer
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

10.  Proplatelet formation in heterozygous Bernard-Soulier syndrome type Bolzano.

Authors:  A Balduini; A Malara; A Pecci; S Badalucco; V Bozzi; I Pallotta; P Noris; M Torti; C L Balduini
Journal:  J Thromb Haemost       Date:  2008-12-04       Impact factor: 5.824

View more
  3 in total

1.  Myocardial infarction in two cousins heterozygous for ASN41HIS autosomal dominant variant of Bernard-Soulier syndrome.

Authors:  Antonio Girolami; Silvia Vettore; Fabrizio Vianello; Giulia Berti de Marinis; Fabrizio Fabris
Journal:  J Thromb Thrombolysis       Date:  2012-11       Impact factor: 2.300

Review 2.  Pathogenesis and management of inherited thrombocytopenias: rationale for the use of thrombopoietin-receptor agonists.

Authors:  Alessandro Pecci
Journal:  Int J Hematol       Date:  2013-05-01       Impact factor: 2.490

3.  Serum Thrombopoietin and cMpl Expression in Thrombocytopenia of Different Etiologies.

Authors:  Fabrizio Vianello; Silvia Vettore; Fabiana Tezza; Luca De Toni; Raffaella Scandellari; Luisa Sambado; Martina Treleani; Fabrizio Fabris
Journal:  Hematol Rep       Date:  2014-03-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.